CHATGPT DOG VACCINE STORY BECOMES ACTUAL STARTUP

Conyngham's viral story about using multiple AI tools to create a custom cancer treatment sparked significant attention in tech circles. His new venture, Gamgee, aims to commercialize the approach by combining AI and genetic analysis to develop tailored vaccines. While the startup initially focuses on dogs, its ambitions extend further. The company's website indicates plans to leverage AI and genetics for personalized treatments across multiple conditions and species. The move exemplifies a growing trend of AI-assisted biotech development, where entrepreneurs use language models and other AI tools to accelerate research and reduce development timelines. Whether Gamgee can translate the compelling origin story into viable commercial products remains dependent on regulatory approval and clinical validation. The startup enters a competitive space where personalized medicine is gaining traction, though most current applications focus on human treatments rather than veterinary applications.